Clinuvel Pharmaceuticals | CUV - Cost Of Sales

Stock Price
9.62
Daily Change
0.15 1.58%
Monthly
-15.02%
Yearly
-19.16%
Q1 Forecast
9.72

Clinuvel Pharmaceuticals reported AUD1.93M in Cost of Sales for its fiscal semester ending in June of 2024.





Cost Of Sales Change Date
Avita Medical AUD 3.3M 166K Dec/2025
Medical Developments International AUD 7.09M 4.91M Dec/2025
Mesoblast USD -7.6M 27.47M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 1.88K 16.84K Jun/2025
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025